Loading clinical trials...
Loading clinical trials...
A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving KRYSTEXXA® (Pegloticase) (MIRROR Open-Label [OL])
Conditions
Interventions
Pegloticase
Methotrexate (MTX)
+3 more
Locations
6
United States
Orthopedic Physicians Alaska
Anchorage, Alaska, United States
Arizona Arthritis & Rheumatology -West Valley
Glendale, Arizona, United States
Arizona Arthritis & Rheumatology -East Valley
Mesa, Arizona, United States
Avail Clinical Research
DeLand, Florida, United States
Western Washington Arthritis Clinic
Bothell, Washington, United States
Arthritis Northwest PLLC
Spokane, Washington, United States
Start Date
September 26, 2018
Primary Completion Date
October 23, 2019
Completion Date
October 26, 2020
Last Updated
June 26, 2024
NCT07453004
NCT07504146
NCT07089875
NCT07116746
NCT05109936
NCT07295496
Lead Sponsor
Amgen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions